【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Myelodysplastic Syndrome 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Myelodysplastic Syndrome 25
Subjects Recruited Over a Period of Time 40
Prominent Sponsors 41
Top Companies Participating in Myelodysplastic Syndrome Therapeutics Clinical Trials 43
Prominent Drug Comparison 45
Clinical Trial Profiles 46
Clinical Trial Overview of Top Companies 46
Celgene Corporation 46
Clinical Trial Overview of Celgene Corporation 46
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Merck & Co., Inc. 51
Clinical Trial Overview of Merck & Co., Inc. 51
Amgen Inc. 52
Clinical Trial Overview of Amgen Inc. 52
Onconova Therapeutics, Inc 53
Clinical Trial Overview of Onconova Therapeutics, Inc 53
Johnson & Johnson 54
Clinical Trial Overview of Johnson & Johnson 54
Telik, Inc. 55
Clinical Trial Overview of Telik, Inc. 55
Eisai Inc. 56
Clinical Trial Overview of Eisai Inc. 56
Genzyme Corporation 57
Clinical Trial Overview of Genzyme Corporation 57
MethylGene Inc. 58
Clinical Trial Overview of MethylGene Inc. 58
Millennium Pharmaceuticals, Inc. 59
Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 59
Pfizer Inc. 60
Clinical Trial Overview of Pfizer Inc. 60
Vion Pharmaceuticals, Inc. (Inactive) 61
Clinical Trial Overview of Vion Pharmaceuticals, Inc. (Inactive) 61
Nordic MDS Group 62
Clinical Trial Overview of Nordic MDS Group 62
Gamida Cell Ltd. 63
Clinical Trial Overview of Gamida Cell Ltd. 63
GlaxoSmithKline plc 64
Clinical Trial Overview of GlaxoSmithKline plc 64
Novartis Pharmaceuticals Corporation 65
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 65
Array BioPharma Inc. 66
Clinical Trial Overview of Array BioPharma Inc. 66
Kyowa Hakko Kirin Co., Ltd. 67
Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 67
medac GmbH 68
Clinical Trial Overview of medac GmbH 68
Clinical Trial Overview of Top Institutes / Government 69
National Cancer Institute 69
Clinical Trial Overview of National Cancer Institute 69
The University of Texas M. D. Anderson Cancer Center 77
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 77
Fred Hutchinson Cancer Research Center 83
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 83
Memorial Sloan Kettering Cancer Center 91
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 91
Sidney Kimmel Comprehensive Cancer Center 95
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 95
National Heart, Lung, and Blood Institute 98
Clinical Trial Overview of National Heart, Lung, and Blood Institute 98
Masonic Cancer Center 100
Clinical Trial Overview of Masonic Cancer Center 100
Groupe Francophone des Myelodysplasies 102
Clinical Trial Overview of Groupe Francophone des Myelodysplasies 102
Case Comprehensive Cancer Center 104
Clinical Trial Overview of Case Comprehensive Cancer Center 104
European Organization for Research and Treatment of Cancer 106
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 106
Stanford University 108
Clinical Trial Overview of Stanford University 108
Washington University School of Medicine 110
Clinical Trial Overview of Washington University School of Medicine 110
H. Lee Moffitt Cancer Center & Research Institute 112
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 112
Roswell Park Cancer Institute 114
Clinical Trial Overview of Roswell Park Cancer Institute 114
Dana-Farber Cancer Institute 116
Clinical Trial Overview of Dana-Farber Cancer Institute 116
City of Hope National Medical Center 118
Clinical Trial Overview of City of Hope National Medical Center 118
University of California, San Francisco 120
Clinical Trial Overview of University of California, San Francisco 120
Baylor College of Medicine 122
Clinical Trial Overview of Baylor College of Medicine 122
Children’s Oncology Group 123
Clinical Trial Overview of Children’s Oncology Group 123
Duke University 124
Clinical Trial Overview of Duke University 124
Five Key Clinical Profiles 125
Appendix 181
Abbreviations 181
Definitions 181
Research Methodology 182
Secondary Research 182
About GlobalData 183
Contact Us 183
Disclaimer 183
Source 184
【レポート販売概要】
■ タイトル：Myelodysplastic Syndrome：グローバル臨床試験レビューH1, 2013■ 英文：Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2013
■ 発行日：2013年6月17日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161138
■ 調査対象地域：グローバル
- 血小板血症の骨髄線維症(Thrombocythaemia Myelofibrosis)の治療薬パイプライン動向（2015年上半期版）Thrombocythaemia Myelofibrosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Thrombocythaemia Myelofibrosis - Pipeline Review, H1 2015’, provides an overview of the Thrombocythaemia Myelofibrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thrombocythaemia Myelofibrosis, complete with comparative analysis at various stage …
- 乾性角結膜炎(ドライアイ)：世界の治験レビュー（2015年上半期版）Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015" provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dr …
- Traditional Wound Management Market to 2019 – Cost Sensitivity Spurs Adoption in Emerging Markets, as Uptake of Advanced Wound Management Products Limits Growth in Developed EconomiesTraditional Wound Management Market to 2019 - Cost Sensitivity Spurs Adoption in Emerging Markets, as Uptake of Advanced Wound Management Products Limits Growth in Developed Economies Summary GBI Research’s report "Traditional Wound Management Market to 2019 - Cost Sensitivity Spurs Adoption in Emerging Markets, as Uptake of Advanced Wound Management Products Limits Growth in Developed Economies" …
- Sjogren’s Syndrome：グローバル臨床試験レビューH1, 2013Sjogren's Syndrome Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Sjogren’s Syndrome Global Clinical Trials Review, H1, 2013" provides data on the Sjogren’s Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sjogren’s Syndrome. It includes an overview of the trial numbers and their recruitme …
- 世界のテレフタル酸ジメチル(DMT)市場2015The Global Dimethyl Terephthalate (DMT) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Dimethyl Terephthalate (DMT) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Dimethyl Terephthalate (DMT) market analysis is provided for the international m …
- アジアの産業自動化制御市場：PLC、DCS、SCADA、MES、APCTechnavio research analyst predicts the industrial automation control market in APAC to grow steadily at a CAGR of 8% during the forecast period. The surge in the demand for chemical and petrochemical products from APAC is the primary growth driver for this market. The high adoption of automation control solutions across chemicals plants in China, Japan, South Korea, India, and Taiwan has been con …
- プレハブ建築（システム建築）の世界市場2016-2020About the Pre-Engineered Building (PEB) Market Global population growth and rapid urbanization are the other drivers of the global construction market. The construction industry in developed markets has a positive outlook as the forecast period will witness a decrease in the effects of global financial crises, a stabilization in household income, and an improvement in public finances. However, the …
- Motor Oil (Hellas) Corinth Refineries S.A.：石油・ガスバリューチェーン分析レポート2013Motor Oil (Hellas) Corinth Refineries S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Motor Oil (Hellas) Corinth Refineries S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Motor Oil (Hellas) Corinth Refineries S.A.”. The report provides key information relating to oil and gas assets of the company …
- 世界の自動車照明（ライト）市場動向（2012-2016）TechNavio's analysts forecast the Global Automotive Lighting market to grow at a CAGR of 5.49 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased usage of LED lighting. The Global Automotive Lighting market has also been witnessing the increasing popularity of neon lights. However, the snowballing prices of the raw materials used could pose …
- マイクロサーバーICの世界市場予測（～2022）：プロセッサ別、提供形態別、需要先別、用途別（メディアストレージ、データセンター、クラウドコンピューティング）、地域別The micro server IC market is expected to be worth USD 1.35 Billion by 2022, at a CAGR of 44.0% between 2016 and 2022. Some of the key factors driving this market are low power consumption and space usage by micro servers, growing trend of cloud computing and web hosting, cost effectiveness of micro servers in comparison with traditional servers, and emerging hyperscale data center architecture. T …
- うっ血性心不全（CHF）治療装置の世界市場分析：製品別（心室補助装置、カウンター脈動装置、植込み型除細動器、心臓ペースメーカー、心臓再同期療法）、セグメント予測The congestive heart failure (CHF) treatment devices market is expected to reach USD 32.0 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs. Fa …
- 世界のアプリケーションサーバー市場：Global Application Server Market 2014-2018TechNavio's analysts forecast the Global Application Server market to grow at a CAGR of 21.95 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing adoption of the internet of things. The Global Application Server market has also been witnessing the increasing demand for mobile internet services. However, the increasing demand for customized ap …
- 液化天然ガス（LNG）インフラの世界市場2016-2026There are a number of exciting LNG liquefaction prospects around the world in 2016, both under construction and prospective. The question is whether the demand of East Asia is strong enough to support the economics of an abundant supply of liquefaction opportunities. This report tackles that question, forecasting the feasibility and likelihood of further liquefaction and regasification investment …
- 排出監視装置の世界市場：連続排出量監視システム（CEMS）、予測排出量監視システム（PEMS）The emission monitoring systems market is estimated to reach USD 2.81 Billion by 2020. Government regulations worldwide require industrial operators to measure the concentration of CO, NOx, O2, and other flue gases emitting from industrial process operations. Identifying the negative impact of these gases, many countries such as the U.S. and the U.K. have taken major steps to properly monitor and …
- スマートテレビの世界市場2015-2019About Smart TV Smart TV, also known as connected TV or hybrid TV, is a TV with internet capabilities or incorporated with a set-top box, which enables it to offer advanced connectivity and computing abilities. This TV allows users to install and run advanced applications based on specific platforms, but should not be confused with an IPTV that only provides access to the internet. Its main functio …
